Results 241 to 250 of about 16,333 (257)

Hepatocellular Carcinoma Recurrence after Hepatitis C Virus Therapy with Direct-Acting Antivirals. A Systematic Review and Meta-Analysis

Journal of Clinical Medicine, 2021
, Leonardo Frazzoni, Lorenzo Fuccio
exaly  

Onsite treatment of HCV infection with direct acting antivirals within an opioid treatment program

Journal of Substance Abuse Treatment, 2017
Jeanette M Tetrault, Jenna L Butner, Neil Gupta   +2 more
exaly  

Direct acting antiviral‐induced/exacerbated psoriasis: Addendum!

Dermatologic Therapy, 2019
Ayman Abdelmaksoud, Michelangelo Vestita
openaire   +2 more sources

The Era of Direct-Acting Antivirals Has Begun: The Beginning of the End for HCV?

Seminars in Liver Disease, 2011
Douglas Dieterich
exaly  

Cost-Utility Analysis of Direct-Acting Antivirals for Treatment of Chronic Hepatitis C Genotype 1 and 6 in Vietnam

Value in Health, 2020
USA Chaikledkaew, Thakkinstian A, Olivia Wu   +2 more
exaly  

Interferon Response in Hepatitis C Virus-Infected Hepatocytes: Issues to Consider in the Era of Direct-Acting Antivirals

International Journal of Molecular Sciences, 2020
Pil Soo Sung, Eui-Cheol Shin, Shin Eui-Cheol   +2 more
exaly  

Direct-Acting Antivirals in Hepatitis C Virus-Associated Diffuse Large B-cell Lymphomas

Oncologist, 2019
Valentina Zuccaro, Massimo Gentile, Francesco Passamonti   +2 more
exaly  

Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals

Cancers, 2020
Zuzana Macek Jílková, Caroline Aspord, Patrice Marché   +2 more
exaly  

Direct-Acting Antivirals for Hepatitis C Virus (HCV): The Progress Continues

Current Drug Targets, 2017

exaly  

Hepatitis C and direct-acting antivirals

Hot Topics in Viral Hepatitis, 2013
openaire   +1 more source